Elena Di Blasi, MD

Fondazione IRCCS Istituto Nazionale Tumori
milano, Lombardia, Italy

Presentation(s):

• Paper 34 - OVERCOMING MTOR INHIBITOR RESISTANCE IN PECOMA: UPDATED RESULTS ON AROMATASE INHIBITOR ADDITION FROM A REFERRAL CENTER

  Friday, November 14, 2025
  10:30 AM - 12:00 PM EST

  Disclosure information not submitted.

• Paper 42 - PSOAS MUSCLE WELL DIFFERENTIATED LIPOSARCOMA: A DISTINCT ANATOMIC SUBSET WITH HIGHLY FAVORABLE OUTCOMES

  Friday, November 14, 2025
  1:30 PM - 2:30 PM EST

  Disclosure information not submitted.

• Paper 62 - DATA DRIVEN MODELLING OF SPATIAL HETEROGENEITY IN SOFT TISSUE SARCOMAS IDENTIFIES PROGNOSTIC GROUPS FOLLOWING NEOADJUVANT CHEMOTHERAPY: ANALYSIS OF THE ISG-STS-1001 TRIAL

  Saturday, November 15, 2025
  9:00 AM - 10:30 AM EST

  Disclosure information not submitted.